What’s Inside

Geranylgeraniol (GG-Gold™)

A key nutrient for energy production and hormone synthesis. GG helps the body make CoQ10, supports calcium balance, aids in protein synthesis, and may help prevent the natural loss of muscle and bone density associated with aging.

Vitamin E Isomers (Tocotrienols)

Derived from Annatto, these potent antioxidants provide advanced support for cardiovascular health, bone strength, and cellular energy while protecting against oxidative stress.

___________________________

How to Use

Take 1 softgel daily or as directed by your healthcare practitioner.

___________________________

What to Avoid

Warning: Consult your healthcare practitioner if you are pregnant, breastfeeding, planning to become pregnant, or taking prescription medications.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

___________________________

Purity & Safety

• DeltaGold® and GG-Gold™ are patented, clinically researched ingredients
• Free from gluten, dairy, soy protein, and GMOs
• Contains bovine gelatin

Research: 1. Shidoji Y, Ogawa H. Natural occurrence of cancer-preventive geranylgeranoic acid in medicinal herbs. J Lipid Res. 2004 Jun;45(6):1092-103. DOI: 10.1194/jlr.M300502-JLR200.
2. Pearce, B.C., et al., Hypocholesterolemic activity of synthetic and natural tocotrienols. J Med Chem, 1992. 35(20): p. 3595-606.
3. Song, B.L. and R.A. DeBose-Boyd, Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme a reductase stimulated by delta- and gamma-tocotrienols. J Biol Chem, 2006. 281(35): p. 25054-61.
4. Qureshi, A.A., et al., Impact of delta-tocotrienol on inflammatory biomarkers and oxidative stress in hypercholesterolemic subjects. Clin. Exp. Cardiology, 2015. 6(4): p. 1000367.
5. Qureshi, A.A., et al., Dose-dependent modulation of lipid parameters, cytokines, and RNA by deltatocotrienol in hypercholesterolemic subjects restricted to AHA Step-1 diet. Brit J of Med & Med Res, 2015. 6(4): p. 351-366.
6. Sathasivam S. Statin induced myotoxicity. Eur J Intern Med. 2012 Jun;23(4):317-24. doi: 10.1016/j.
ejim.2012.01.004.
7. Tomaszewski M, Stępień KM, Tomaszewska J, Czuczwar SJ. Statin-induced myopathies. Pharmacol Rep. 2011;63(4):859-66.
8. Jaśkiewicz A, Pająk B, Litwiniuk A, Urbańska K, Orzechowski A. Geranylgeraniol Prevents Statin-Dependent Myotoxicity in C2C12 Muscle Cells through RAP1 GTPase Prenylation and Cytoprotective Autophagy. Oxid Med Cell Longev. 2018;2018:6463807. doi:10.1155/2018/6463807.
9. Cao P, Hanai J, Tanksale P, Imamura S, Sukhatme VP, Lecker SH. Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect. FASEB J. 2009;23(9):2844–2854.
doi:10.1096/fj.08-128843.
10. Marcuzzi A, Piscianz E, Zweyer M, et al. Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology. Int J Mol Sci. 2016;17(3):365. doi:10.3390/ ijms17030365.
11. Campia I, Lussiana C, Pescarmona G, Ghigo D, Bosia A, Riganti C. Geranylgeraniol prevents the cytotoxic effects of mevastatin in THP-1 cells, without decreasing the beneficial effects on cholesterol synthesis. Br J Pharmacol. 2009;158(7):1777–1786. doi:10.1111/j.1476-5381.2009.00465.x.